28W-10774-30336
4 vaccinations
5 coded responses
27 check-ins
4 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 276 / NC
- Registered
- 2021-03-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-18
Registered in v-safe
-
2021-03-18
Dose 1 — Pfizer-BioNTech
- 2021-03-18
-
2021-03-19
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Muscle or body aches, NauseaAdult check-in
- 2021-03-20
- 2021-03-21
- 2021-03-22
- 2021-03-23
-
2021-03-24
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tiredness, NauseaAdult check-in
- 2021-03-25
- 2021-04-01
-
2021-04-08
Dose 2 — Pfizer-BioNTech
- 2021-04-08
-
2021-04-09
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to workAdult check-in
- 2021-04-10
- 2021-04-11
- 2021-04-12
- 2021-04-13
- 2021-04-14
- 2021-04-15
- 2021-04-22
-
2021-04-29
Survey response — day 21, dose 2MedDRA: Condition aggravated, Pre-existing disease — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Very intense poison ivy break out. More intense than normal.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-29
Report sent to call center — day 21, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-05-06
Survey response — day 28, dose 2MedDRA: Dermatitis contact — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Worse poison ivyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-06
Report sent to call center — day 28, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-05-13
- 2021-05-20
-
2021-07-08
Survey response — 3 months, dose 2MedDRA: Cough, Sinusitis, Upper-airway cough syndrome — Feeling: GoodFree text: Sinus infection with a mild post nasal drip cough, was not tested for covidMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-10-07
-
2021-12-06
Dose 3 — Moderna
- 2022-04-07
- 2022-04-08
-
2022-11-10
Dose 4 — Pfizer-BioNTechCo-administered: Flu
-
2022-12-06
Survey response — 12 months, dose 3MedDRA: Sleep apnoea syndrome — Feeling: GoodFree text: Sleep apneaMedDRA releases: 2024-11 · check-in free text available
-
2023-05-11
Survey response — 6 months, dose 4MedDRA: COVID-19, Pregnancy — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationMedDRA releases: 2024-11
-
2023-05-11
Report sent to call center — 6 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · Hospitalization · 1 call case(s)
- 2023-05-12
- 2023-05-12
- 2023-05-12
- 2023-05-16
- 2023-05-16
- 2023-05-16
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-18 | Pfizer-BioNTech | |
| 2 | 2021-04-08 | Pfizer-BioNTech | |
| 3 | 2021-12-06 | Moderna | No |
| 4 | 2022-11-10 | Pfizer-BioNTech | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-04-29 | Unsuccessful | |
| 2021-05-06 | Unsuccessful | |
| 2023-05-11 | Unsuccessful |
Free text
Release 8 — day 21, dose 2
Symptoms: Very intense poison ivy break out. More intense than normal.
Release 8 — day 28, dose 2
Symptoms: Worse poison ivy
Release 9 — 3 months, dose 2
Symptoms: Sinus infection with a mild post nasal drip cough, was not tested for covid
Release 12 — 12 months, dose 3
Symptoms: Sleep apnea
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Condition aggravated | ✓ | ✓ | ✓ |
| SD | Cough | ✓ | ✓ | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Dermatitis contact | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | Sinusitis | ✓ | ✓ | ✓ |
| SD | Sleep apnoea syndrome | · | · | ✓ |
| SD | Upper-airway cough syndrome | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release